European Companies Search Engine
Registration · Managing Director: Ernest Addy Dodoo, Jakob S. Geyer, Tobias Gottschalk · Address · Capital: €25,000 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb5 Dec 2017 German Trade Register Announcements, Germany
Overview
Text
HRB 110319: Nordwest polybiocept bioscience GmbH, Frankfurt am
Main, Steinbacher Hohl 2-26, 60488 Frankfurt am Main
. GmbH. Partnership agreement of October 6, 2017. Business address:
Steinbacher Hohl 2-26, 60488 Frankfurt am Main
. Subject: clinical development for advanced therapies (somatic cell therapeutics), related technologies and diagnostics as well as applications and holding of patent rights in this context. Share capital: EUR 25,000.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Managing Director: Dr. Dodoo, Ernest Addy, Frankfurt am Main, *??.??.????; Geyer, Jakob Sebastian, Bremen, *??.??.????; Gottschalk, Tobias, Frankfurt am Main, *??.??.????, each with the power to enter into legal transactions on behalf of the company in its own name or a.s. a representative of a third party.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Nordwest polybiocept bioscience GmbH, Frankfurt a. Main, Germany.
